BRKR
BRKR
US1167941087
Bruker Corporation
Loading chart...

Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Latest News

Related stocks

PODD
PODD • United States
Insulet Corporation
135.28 USD
9.38B USD 1Y -57.4%
BIO
BIO • United States
Bio-Rad Laboratories, Inc.
366.16 USD
9.8B USD 1Y +19%
GMED
GMED • United States
Globus Medical, Inc.
74.65 USD
10.02B USD 1Y +21.4%
GKOS
GKOS • United States
Glaukos Corporation
165.69 USD
9.77B USD 1Y +84.1%
PEN
PEN • United States
Penumbra, Inc.
319.4 USD
12.58B USD 1Y +22.6%
IRTC
IRTC • United States
iRhythm Holdings, Inc.
106.7 USD
3.52B USD 1Y -42.7%
STE
STE • United States
STERIS plc (Ireland)
214.4 USD
20.9B USD 1Y -13%
TXG
TXG • United States
10x Genomics, Inc.
80.65 USD
10.51B USD 1Y +540.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
44.3% p.a.
Max Drawdown (5Y)
-68.9%
Sharpe Ratio (5Y)
-0.18
Beta Factor
1.22
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Elevated Short-Term Volatility: 3Y volatility (49.4%) is noticeably higher than the 5Y average (44.3%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -68.9% in the extended horizon.
ende